Provided by Tiger Trade Technology Pte. Ltd.

Dermata Therapeutics Inc

1.42
+0.04002.90%
Post-market: 1.39-0.0300-2.11%19:59 EDT
Volume:230.30K
Turnover:332.96K
Market Cap:5.71M
PE:-0.32
High:1.47
Open:1.38
Low:1.36
Close:1.38
52wk High:6.22
52wk Low:0.9509
Shares:4.02M
Float Shares:3.02M
Volume Ratio:1.11
T/O Rate:7.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3864
EPS(LYR):-8.1609
ROE:-183.89%
ROA:-89.88%
PB:1.64
PE(LYR):-0.17

Loading ...

Dermata Therapeutics announces Tome Foundational Treatment open to preorders

TIPRANKS
·
Aug 21

Dermata Therapeutics Announces Private Placement to Fund DTC Pivot

TIPRANKS
·
Aug 17

Dermata Therapeutics Prices USD 3.4 Million Private Placement at USD 1.46 Per Share

Reuters
·
Aug 17

Maxim Group Sticks to Its Buy Rating for Dermata Therapeutics (DRMA)

TIPRANKS
·
Aug 14

Dermata Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Dermata Therapeutics Q2 EPS $(0.74) Misses $(0.55) Estimate

Benzinga Earnings
·
Aug 12

Dermata Net Loss Widens to USD 2,97 Juta in Q2 FY26

Reuters
·
Aug 12

Dermata Therapeutics - to Launch First Commercial Product Tome Foundational Treatment on August 25, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 12

Dermata Therapeutics Inc Expected to Post a Loss of 55 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Dermata Therapeutics director Kathleen D. Scott disposes of 11 common shares worth $13.09

Reuters
·
Jun 17

Dermata Therapeutics Shareholders Approve Equity Plan and Directors

TIPRANKS
·
May 28

Dermata Therapeutics shareholders approved equity plan share increase to 402,214 at annual meeting

Reuters
·
May 28

Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4

TIPRANKS
·
May 20

Dermata Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Dermata Therapeutics Q1 EPS $(0.48) Beats $(0.53) Estimate

Benzinga Earnings
·
May 14

Dermata net loss narrows to USD 1.85 million in Q1 FY26

Reuters
·
May 14

Dermata Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
May 09

Dermata Therapeutics announces annual shareholder meeting webcast

Reuters
·
Apr 07

Dermata says Australian patent application for topical dermal fillers accepted for Bioneedle system

Reuters
·
Apr 02

Dermata Therapeutics price target lowered to $4 from $10 at Maxim

TIPRANKS
·
Apr 01